Common Contracts

Contract

License Agreement • October 20th, 2017 • Ablynx NV • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  License Agreement
• Filed
  October 20th, 2017
• Company
  Ablynx NV
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[...***...]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

Contract

License Agreement • October 13th, 2017 • Ablynx NV • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  License Agreement
• Filed
  October 13th, 2017
• Company
  Ablynx NV
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[...***...]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

Contract

License Agreement • August 30th, 2017 • Ablynx NV • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  License Agreement
• Filed
  August 30th, 2017
• Company
  Ablynx NV
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[...***...]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.